Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity

Dengue fever, an infectious disease that affects more than 100 million people every year, is a global health problem. Vaccination may be the most effective prevention strategy for the disease. However, the development of vaccines against dengue fever is complicated by the high risk of developing an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mintaev, Ramil R., Glazkova, Dina V., Orlova, Olga V., Ignatyev, Georgiy M., Oksanich, Alexey S., Shipulin, German A., Bogoslovskaya, Elena V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142911/
https://www.ncbi.nlm.nih.gov/pubmed/37112743
http://dx.doi.org/10.3390/vaccines11040831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142911/
https://www.ncbi.nlm.nih.gov/pubmed/37112743
http://dx.doi.org/10.3390/vaccines11040831

Ejemplares similares